|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.04 EUR | +0.07% |
|
-2.93% | -9.33% |
| Dec. 03 | FMC FRESENIUS MEDICAL CARE AG : Buy rating from Berenberg | ZD |
| Dec. 01 | FMC FRESENIUS MEDICAL CARE AG : UBS reiterates its Sell rating | ZD |
| Capitalization | 11.49B 13.36B 10.76B 10.03B 18.52B 1,202B 20.15B 126B 48.59B 568B 50.15B 49.08B 2,077B | P/E ratio 2025 * |
12.8x | P/E ratio 2026 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise value | 20.88B 24.29B 19.56B 18.23B 33.67B 2,186B 36.62B 229B 88.33B 1,032B 91.16B 89.21B 3,775B | EV / Sales 2025 * |
1.07x | EV / Sales 2026 * | 1.02x |
| Free-Float |
67.83% | Yield 2025 * |
3.49% | Yield 2026 * | 3.76% |
Last Transcript: Fresenius Medical Care AG
| 1 day | +0.07% | ||
| 1 week | -2.93% | ||
| Current month | -2.93% | ||
| 1 month | -4.76% | ||
| 3 months | -4.64% | ||
| 6 months | -20.43% | ||
| Current year | -9.33% |
| 1 week | 40.02 |  | 41.25 |
| 1 month | 39.1 | | 41.89 |
| Current year | 39.1 | | 54.02 |
| 1 year | 39.1 | | 54.02 |
| 3 years | 28.82 | | 54.02 |
| 5 years | 25.95 | | 71.14 |
| 10 years | 25.95 | | 93.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 57 | 2022-12-05 |
Martin Fischer
DFI | Director of Finance/CFO | 49 | 2023-09-30 |
Jörg Häring
CMP | Compliance Officer | 55 | 2024-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 58 | 2016-05-11 |
A. Sorensen
BRD | Director/Board Member | 63 | 2021-05-19 |
Michael Sen
CHM | Chairman | 57 | 2023-07-13 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 7.48% | 0 M€ | -.--% | - |
| 0.8% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.07% | -2.93% | -12.40% | +34.23% | 13.36B | |
| -0.20% | -4.25% | +52.21% | +105.69% | 111B | |
| -1.46% | -5.89% | +36.79% | -25.26% | 96.01B | |
| -0.60% | +0.82% | +41.73% | +82.14% | 31.16B | |
| +3.18% | +7.20% | -10.06% | +18.46% | 23.43B | |
| -1.18% | -3.87% | +11.10% | +10.35% | 21.42B | |
| -0.91% | -3.53% | +15.99% | +22.51% | 20.3B | |
| -1.01% | -3.15% | +51.14% | +379.89% | 18.46B | |
| -7.00% | -5.43% | +60.95% | +52.49% | 17.98B | |
| +0.21% | -5.15% | +18.98% | +80.60% | 14.44B | |
| Average | -0.89% | -2.86% | +26.64% | +76.11% | 36.76B | |
| Weighted average by Cap. | -0.79% | -3.62% | +35.65% | +61.37% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 19.56B 22.75B 18.32B 17.08B 31.54B 2,047B 34.3B 214B 82.74B 967B 85.38B 83.56B 3,536B | 20.15B 23.44B 18.88B 17.59B 32.5B 2,110B 35.35B 221B 85.25B 996B 87.98B 86.1B 3,643B |
| Net income | 905M 1.05B 848M 790M 1.46B 94.79B 1.59B 9.92B 3.83B 44.77B 3.95B 3.87B 164B | 1.07B 1.24B 1B 933M 1.72B 112B 1.87B 11.7B 4.52B 52.81B 4.66B 4.56B 193B |
| Net Debt | 9.39B 10.93B 8.8B 8.2B 15.15B 983B 16.48B 103B 39.74B 464B 41.01B 40.14B 1,698B | 8.98B 10.45B 8.41B 7.84B 14.49B 940B 15.76B 98.43B 38B 444B 39.22B 38.38B 1,624B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 40.04 € | -0.15% | 902,467 |
| 25-12-04 | 40.10 € | -0.59% | 845,670 |
| 25-12-03 | 40.34 € | -1.37% | 1,080,771 |
| 25-12-02 | 40.90 € | +0.47% | 686,656 |
| 25-12-01 | 40.71 € | -1.31% | 793,389 |
Delayed Quote Xetra, December 05, 2025 at 11:35 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FME Stock
Select your edition
All financial news and data tailored to specific country editions
